多沙唑嗪联合盐酸屈他维林治疗输尿管下段结石的效果

Abstract
Figure/Table
References (27)
Related Citation (1)

Download: PDF (566 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To evaluate the efficacy and safety of Doxazosin combined with Drotaverine Hydrochloride in the treatment of lower ureteral calculi. Methods A total of 400 patients with lower ureteral calculi treated in the First People’s Hospital of Foshan, Guangdong Province from January 2017 to January 2020 were selected as study objects. They were divided into group A, B, C, and group D, according to treatment plans, with 100 patients in each group. All patients in four groups were routinely treated with Niaoshitong Pills; group A did not add any ureteral smooth muscle relaxant; group B was given Doxazosin, group C was given Trotaverine Hydrochloride, and group D was given Doxazosin combined and Drotaverine Hydrochloride. All patients were followed up for four weeks, and the stone excretion rate, stone excretion time, renal colic recurrence rate and the incidence of adverse reactions were compared among four groups. Results There were statistically significant differences in stone excretion rate, stone excretion time, and renal colic recurrence rate among four groups (P < 0.008). The stone excretion rate of group D was higher than that of group A and C, and renal colic recurrence rate was lower than that of group A and C; the stone excretion rate of group B was higher than that of group A, and renal colic recurrence rate was lower than that of group A, and the differences were statistically significant (P < 0.05). Pairwise comparison of stone excretion time among four groups showed statistical significance (P < 0.05). There were no significant differences in the incidence of adverse reactions among four groups (P > 0.05). Conclusion Doxazosin combined with Drotaverine Hydrochloride in the treatment of lower ureteral calculi has good efficacy and high safety, which is worthy of clinical application.

Key words： Doxazosin Drotaverine Hydrochloride Lower ureteral calculi Medicine row stone

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	HU Yuan LI Bin

Cite this article:

HU Yuan LI Bin. Effect of Doxazosin combined with Drotaverine Hydrochloride in the treatment of lower ureteral calculi#br#[J]. 中国医药导报, 2022, 19(6): 81-84.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2022/V19/I6/81

[1] 彭林杰，闻俊军，钟文.摩西技术在尿路结石碎石中的应用[J].中华腔镜泌尿外科杂志：电子版，2018，12（6）：361-363.
[2] 傅龙龙，王共先，傅斌.泌尿系结石病因学的研究进展[J].天津医药，2012，40（9）：968-970.
[3] 郑军华，鲁军，邵怡.重视软性输尿管镜碎石术后尿脓毒血症的诊治[J].上海医学，2019，42（3）：132-134.
[4] 黄健.中国泌尿外科疾病诊断治疗指南[M].2019版.北京：人民卫生出版社，2019：237.
[5] 王艳波，侯宇川，王春喜.无症状未梗阻性肾结石：积极治疗，还是随访观察?[J].泌尿外科杂志：电子版，2018， 10（2）：5-7.
[6] 孙健，李光，向从明，等.后腹腔镜治疗输尿管结石体会[J].实用临床医药杂志，2010，14（13）：46-47.
[7] Miller OF，Kane CJ. Time to stone passage for observed ureteral calculi：a guide for patient education [J]. J Urol，1999，162（3 Pt 1）：686-691．
[8] Skolarikos A，Laguna MP，Alivizatos G，et al. the role for active monitoring in uranary stones [J]. J Endourol，2010，24（6）：923-930.
[9] Hübner WA，Irby P，Stoller ML. Natural history and current concepts for the treatment of small ureteral calculi [J]. Eur Urol，1993，24（2）：172-176.
[10] 潘杰，梁健峰.尿石通丸联合盐酸坦索罗辛治疗输尿管结石疗效观察[J].广西中医药，2020，43（3）：24-26.
[11] 程武松，陈洪波，赵纯雄，等.三金排石颗粒联合盐酸坦索罗辛缓释胶囊治疗输尿管中下段结石[J].湖北民族学院学报：医学版，2019，36（1）：88-90.
[12] 杨远旺，覃家雅，林健彬，等.双氯芬酸钠联合坦索罗辛、结石通治疗输尿管结石合并肾绞痛疗效分析[J].中国现代医药杂志，2019，21（3）：18-21.
[13] 耿怀振，仝雯，曹玉梅，等.输尿管镜钬激光碎石术联合坦索罗辛治疗输尿管中下段结石的临床研究[J].泌尿外科杂志：电子版，2018，10（2）：26-29.
[14] 鲁斌，杨龙宝，赵伟.输尿管结石行输尿管镜下钬激光碎石治疗的临床效果分析[J].当代医学，2021，27（3）：9-11.
[15] 刘金，罗功唐，刘元鹏.输尿管硬镜联合输尿管软镜钬激光碎石术治疗复杂性输尿管上段结石的临床效果[J].国际泌尿系统杂志，2021，41（2）：305-308.
[16] 宁勇.输尿管镜下钬激光碎石手术治疗输尿管结石的效果及对患者不良反应的影响[J].检验医学与临床，2020， 17（2）：251-253.
[17] Tük C，Knoll T，Seitz C，et al. European Association of Urology. Medical Expulsive Therapy for Ureterolithiasis：the EAU Recommendations in 2016 [J]. Eur Urol，2017， 71（4）：504-507.
[18] 王帆，杨璐，魏强.多沙唑嗪治疗输尿管结石疗效及安全性的Meta分析[J].中国循证医学杂志，2019，19（7）：828-835.
[19] 程海峰，徐晓峰，李楠，等.坦索罗辛在输尿管结石排石中的应用效果[J].临床医学研究与实践，2020，5（13）：31-33.
[20] 苏志宇，郭燕芬，庞健辉.探讨坦洛新在输尿管结石体外冲击波碎石后辅助排石的临床疗效[J].北方药学，2019，16（7）：107-108.
[21] 蒋韬.坦索罗辛联合利尿剂对促进输尿管结石排出的临床应用[J].西南军医，2019，21（4）：339-341.
[22] 雷容，刘杨文易，张克，等.α1受体阻滞剂在输尿管结石中的研究进展[J].中国医药科学，2021，11（6）：31-33，46.
[23] 卢凯，陈智慧，邓有强，等.多沙唑嗪在输尿管下段结石的应用研究[J].新医学，2020，51（1）：53-56.
[24] 张烨，王磊，张璐.甲磺酸多沙唑嗪在输尿管镜手术治疗输尿管上段结石围术期中应用的效果[J].广西医学，2021，43（1）：27-30.
[25] 罗栩怡，吴湛权，仉智.酮咯酸氨丁三醇联合屈他维林对肾绞痛的止痛疗效[J].黑龙江中医药，2020，49（4）：131-132.
[26] 赖龙飞，胡梓生，张秋波.铝碳酸镁联合屈他维林治疗急性胃痉挛的疗效[J].中国继续医学教育，2021，13（6）：130-133.
[27] Dyderski S，Grzeskowiak E，Drobnik L，et al. Bioavailability study of drotaverine from capsule and tablet preparations in healthy volunteers [J]. Arsneimittelforschung，2004，54（5）：298-302.